UHT - Universal Health Rea... Stock Analysis | Stock Taper
Logo
Universal Health Realty Income Trust

UHT

Universal Health Realty Income Trust NYSE
$43.62 -1.29% (-0.57)

Market Cap $605.17 M
52w High $44.70
52w Low $35.26
Dividend Yield 7.01%
Frequency Quarterly
P/E 33.81
Volume 44.42K
Outstanding Shares 13.87M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $73.96M $42.15M $4.32M 5.85% $0.32 $14.05M
Q3-2025 $25.3M $15.49M $4.02M 15.87% $0.29 $17.34M
Q2-2025 $24.87M $14.63M $4.49M 18.06% $0.33 $16.8M
Q1-2025 $24.55M $14.15M $4.78M 19.46% $0.35 $16.87M
Q4-2024 $24.64M $13.99M $4.66M 18.91% $0.34 $17.13M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $6.69M $564.91M $412.52M $152.38M
Q3-2025 $6.92M $568.04M $409.46M $158.57M
Q2-2025 $6.55M $573.02M $407.86M $165.15M
Q1-2025 $6.97M $573.48M $401.32M $172.17M
Q4-2024 $7.1M $580.86M $401.32M $179.54M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $4.32M $23.8M $-4.27M $-19.39M $0 $23.8M
Q3-2025 $4.02M $10.34M $-1.89M $-8.09M $362K $10.34M
Q2-2025 $4.49M $13.69M $-8.79M $-5.32M $-420K $13.69M
Q1-2025 $4.78M $11.61M $-1.9M $-9.84M $-123K $11.61M
Q4-2024 $4.66M $13.15M $-2.71M $-9.72M $725K $13.15M

Revenue by Products

Product Q2-2022Q3-2022Q4-2022Q1-2023
Product And Service Other
Product And Service Other
$0 $0 $0 $0

5-Year Trend Analysis

A comprehensive look at Universal Health Realty Income Trust's financial evolution and strategic trajectory over the past five years.

+ Strengths

UHT’s main strengths are a specialized focus on healthcare facilities, long‑term and largely triple‑net leases, and a deep, enduring relationship with Universal Health Services that provides stable occupancy and a recurring pipeline of projects. The provided financials, while imperfect, point to positive earnings, strong operating cash flow, and a very conservative balance sheet with ample liquidity and little visible leverage. This combination suggests resilience, predictable income, and a capacity to sustain distributions even through moderate industry or economic cycles.

! Risks

Key risks center on data quality and structural concentration. The financial statements show unusual items—such as zero revenue, no operating expenses, and zero debt—that likely reflect incomplete reporting and should be treated cautiously. Strategically, UHT is heavily reliant on a single major tenant and sector, exposing it to shocks in UHS’s performance or shifts in healthcare policy and real estate demand. Limited capital expenditure in the period raises the question of whether the portfolio is being sufficiently refreshed and expanded to stay competitive over the long term. Interest expense, when present, is an important cost driver, so higher rates or increased leverage could narrow margins.

Outlook

Looking ahead, UHT appears positioned for relatively steady, income‑oriented performance as long as its core healthcare tenants remain healthy and the demand for physical care facilities persists. The trust’s niche focus, conservative balance sheet, and close alignment with UHS should support stable cash flows, but growth may be modest if reinvestment and development activity remain subdued. The outlook is therefore one of stability rather than rapid expansion, with outcomes heavily influenced by healthcare sector dynamics, UHS’s strategy, and UHT’s willingness to deploy its financial flexibility into selective, well‑underwritten projects rather than simply maximizing near‑term distributions.